Jaguar Gene Therapy Community Letter & FAQ *UPDATED 11/5/24*
Jaguar has released an updated community letter and FAQ document that provides new details about the JAG201 clinical study. This resource…
Neuren Phase 2 trial Investor Presentation
Neuren has released a statement that the drug was found to be generally safe at the dose tested, having no serious adverse effects.
Press Release – Neuren Phase 2 trial shows significant improvements in Phelan-McDermid syndrome
Neuren has released a statement that the drug was found to be generally safe at the dose tested, having no serious adverse effects.
Clinical Research Decision Tool
Use this chart to help you make an informed decision when considering participation in a clinical trial.